{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:30:12Z","timestamp":1790371812492,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03999-5","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T08:51:25Z","timestamp":1748335885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development and validation of a new predictive model for the immune tolerance stage of chronic HBV infection based on the liver histopathological changes"],"prefix":"10.1186","volume":"25","author":[{"given":"Wentao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiupeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongjing","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"3999_CR1","unstructured":"WHO, The World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK305553\/."},{"issue":"1","key":"3999_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2022","unstructured":"Iannacone M, Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol. 2022;22(1):19\u201332. https:\/\/doi.org\/10.1038\/s41577-021-00549-4.","journal-title":"Nat Rev Immunol"},{"issue":"9\u201310","key":"3999_CR3","first-page":"S218","volume":"12","author":"CM Chu","year":"1997","unstructured":"Chu CM, Liaw YF. Natural history of chronic hepatitis B virus infection: an immunopathological study. J Gastroenterol Hepatol. 1997;12(9\u201310):S218\u201322.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2 Suppl 1","key":"3999_CR4","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1002\/hep.20956","volume":"43","author":"HJ Yim","year":"2006","unstructured":"Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006;43(2 Suppl 1):S173\u201381.","journal-title":"Hepatology"},{"key":"3999_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","volume":"11","author":"P Fisicaro","year":"2020","unstructured":"Fisicaro P, Barili V, Rossi M, et al. Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches. Front Immunol. 2020;11:849. https:\/\/doi.org\/10.3389\/fimmu.2020.00849.","journal-title":"Front Immunol"},{"issue":"2","key":"3999_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1440-1746.2011.06940.x","volume":"27","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Zhang JY, Wang LF, Wang FS. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. J Gastroenterol Hepatol. 2012;27(2):223\u201330. https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06940.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"3999_CR7","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1053\/j.gastro.2015.11.050","volume":"150","author":"JJ Park","year":"2016","unstructured":"Park JJ, Wong DK, Wahed AS, Hepatitis B Research Network, et al. Hepatitis B virus-specific and global T-cell dysfunction in chronic hepatitis B. Gastroenterology. 2016;150(3):684\u201395. https:\/\/doi.org\/10.1053\/j.gastro.2015.11.050.","journal-title":"Gastroenterology."},{"issue":"5","key":"3999_CR8","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","volume":"151","author":"WS Mason","year":"2016","unstructured":"Mason WS, Gill US, Litwin S, et al. HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant. Gastroenterology. 2016;151(5):986\u201398. https:\/\/doi.org\/10.1053\/j.gastro.2016.07.012.","journal-title":"Gastroenterology"},{"issue":"4","key":"3999_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/apt.12590","volume":"39","author":"DT Chao","year":"2014","unstructured":"Chao DT, Lim JK, Ayoub WS, Nguyen LH, Nguyen MH. Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase 40 IU\/L and significant hepatic fibrosis. Aliment Pharmacol Ther. 2014;39(4):349\u201358. https:\/\/doi.org\/10.1111\/apt.12590.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"3999_CR10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1053\/j.gastro.2009.05.058","volume":"137","author":"M Kumar","year":"2009","unstructured":"Kumar M, Sarin SK. Hepatitis B virus immunotolerant patients: need to differentiate patients with or without liver disease. Gastroenterology. 2009;137(2):742\u20133. https:\/\/doi.org\/10.1053\/j.gastro.2009.05.058.","journal-title":"Gastroenterology"},{"issue":"3","key":"3999_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/cmi.2014.79","volume":"12","author":"A Bertoletti","year":"2015","unstructured":"Bertoletti A, Kennedy PT. The immune tolerant phase of chronic HBV infection: new perspectives on an old concept. Cell Mol Immunol. 2015;12(3):258\u201363. https:\/\/doi.org\/10.1038\/cmi.2014.79.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"3999_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021.","journal-title":"J Hepatol"},{"issue":"5","key":"3999_CR13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1053\/j.gastro.2016.11.057","volume":"152","author":"YF Liaw","year":"2017","unstructured":"Liaw YF, Chu CM. Immune tolerance phase of chronic hepatitis B. Gastroenterology. 2017;152(5):1245\u20136. https:\/\/doi.org\/10.1053\/j.gastro.2016.11.057.","journal-title":"Gastroenterology"},{"issue":"5","key":"3999_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1053\/j.gastro.2016.09.037","volume":"151","author":"DR Milich","year":"2016","unstructured":"Milich DR. The concept of immune tolerance in chronic hepatitis B virus infection is alive and well. Gastroenterology. 2016;151(5):801\u20134. https:\/\/doi.org\/10.1053\/j.gastro.2016.09.037.","journal-title":"Gastroenterology"},{"key":"3999_CR15","doi-asserted-by":"publisher","unstructured":"Chinese liver disease association and Chinese Medical Association infectious disease branch: chronic hepatitis B Prevention Guide (2019 Edition). Chin J Infec 2019 37(12);711\u2013736. https:\/\/doi.org\/10.3760\/cma.j.issn.1000-6680.2019.12.003","DOI":"10.3760\/cma.j.issn.1000-6680.2019.12.003"},{"issue":"4","key":"3999_CR16","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399. https:\/\/doi.org\/10.1002\/hep.29800.","journal-title":"Hepatology"},{"issue":"1","key":"3999_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1\u201398. https:\/\/doi.org\/10.1007\/s12072-015-9675-4.","journal-title":"Hepatol Int"},{"issue":"4","key":"3999_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00535-020-01665-z","volume":"55","author":"HW Lee","year":"2020","unstructured":"Lee HW, Chan HL. Unresolved issues of immune tolerance in chronic hepatitis B. J Gastroenterol. 2020;55(4):383\u20139. https:\/\/doi.org\/10.1007\/s00535-020-01665-z.","journal-title":"J Gastroenterol"},{"issue":"4","key":"3999_CR19","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jhep.2020.11.003","volume":"74","author":"A Suslov","year":"2021","unstructured":"Suslov A, Meier MA, Ketterer S, Wang X, Wieland S, Heim MH. Transition to HBeAg- negative chronic hepatitis B virus infection is associated with reduced cccDNA transcriptional activity. J Hepatol. 2021;74(4):794\u2013800. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.003.","journal-title":"J Hepatol"},{"key":"3999_CR20","unstructured":"World Gastroenterology Organisation Global Guideline: Hepatitis B(Version 2.0) . World Gastroenterology Organisation(WGO), February 2015. https:\/\/www.worldgastroenterology.org\/guidelines\/hepatitis-b (2023-04- 06)"},{"issue":"2","key":"3999_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/hep.21724","volume":"46","author":"CK Hui","year":"2007","unstructured":"Hui CK, Leung N, Yuen ST, et al. Hong Kong Liver Fibrosis Study. Hepatology. 2007;46(2):395\u2013401. https:\/\/doi.org\/10.1002\/hep.21724.","journal-title":"Hepatology"},{"issue":"1","key":"3999_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00535-012-0668-y","volume":"48","author":"TC Tseng","year":"2013","unstructured":"Tseng TC, Kao JH. Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog. J Gastroenterol. 2013;48(1):13\u201321. https:\/\/doi.org\/10.1007\/s00535-012-0668-y.","journal-title":"J Gastroenterol"},{"issue":"5","key":"3999_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3760\/cma.j.issn.1000-6680.2012.05.012","volume":"30","author":"N Li","year":"2012","unstructured":"Li N, Guo Q, Long T, et al. The correlation between the volume of platelet and spleen and the degree of liver fibrosis in patients with chronic hepatitis B virus infection. Chin J Infect Dis. 2012;30(5):297\u20139. https:\/\/doi.org\/10.3760\/cma.j.issn.1000-6680.2012.05.012.","journal-title":"Chin J Infect Dis"},{"issue":"6","key":"3999_CR24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/apt.13515","volume":"43","author":"ZG Jiang","year":"2016","unstructured":"Jiang ZG, Feldbr\u00fcgge L, Tapper EB, et al. Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. Aliment Pharmacol Ther. 2016;43(6):734\u201343. https:\/\/doi.org\/10.1111\/apt.13515.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"3999_CR25","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.jhepr.2021.100398","volume":"4","author":"T Vanwolleghem","year":"2021","unstructured":"Vanwolleghem T, Adomati T, Van Hees S, Janssen HLA. Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV. JHEP Rep. 2021;4(2):100398. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100398.","journal-title":"JHEP Rep"},{"issue":"29","key":"3999_CR26","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1097\/MD.0000000000000322","volume":"93","author":"W Jia","year":"2014","unstructured":"Jia W, Song LW, Fang YQ, et al. Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study. Medicine (Baltimore). 2014;93(29):e322. https:\/\/doi.org\/10.1097\/MD.0000000000000322.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"3999_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1053\/j.gastro.2010.04.052","volume":"139","author":"MR Brunetto","year":"2010","unstructured":"Brunetto MR, Oliveri F, Colombatto P, et al. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology. 2010;139(2):483\u201390. https:\/\/doi.org\/10.1053\/j.gastro.2010.04.052.","journal-title":"Gastroenterology"},{"issue":"11","key":"3999_CR28","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1016\/j.cgh.2020.03.001","volume":"18","author":"Y Sun","year":"2020","unstructured":"Sun Y, Wu X, Zhou J, et al. Persistent low level of hepatitis B virus promotes fibrosis progression during therapy. Clin Gastroenterol Hepatol. 2020;18(11):2582-2591.e6. https:\/\/doi.org\/10.1016\/j.cgh.2020.03.001.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3999_CR29","doi-asserted-by":"publisher","unstructured":"Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). 2022; 30(12): 1309\u20131331. https:\/\/doi.org\/10.3760\/cma.j.cn501113-20221224-00607.","DOI":"10.3760\/cma.j.cn501113-20221224-00607"},{"issue":"1","key":"3999_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4049\/jimmunol.0902761","volume":"184","author":"S Phillips","year":"2010","unstructured":"Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol. 2010;184(1):287\u201395. https:\/\/doi.org\/10.4049\/jimmunol.0902761.","journal-title":"J Immunol"},{"issue":"1","key":"3999_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12879-024-10408-x","volume":"25","author":"TJ Xing","year":"2025","unstructured":"Xing TJ. Existing problems and advice on revisions with the stage criteria for chronic hepatitis B. BMC Infect Dis. 2025;25(1):17. https:\/\/doi.org\/10.1186\/s12879-024-10408-x.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03999-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03999-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03999-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T08:51:29Z","timestamp":1748335889000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03999-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3999"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03999-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Commission of Taizhou Hospital of Zhejiang Province(ethical approval number: 2023\u201303-47\u201301) and Ethics Committee of Nanjing Drum Tower Hospital, Jiangsu Province(ethical approval number: 2008022). All patients signed an informed consent form. This study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"408"}}